Immunexpress Inc. Employee Directory
Biotechnology ResearchWashington, United States11-50 Employees
Immunexpress is a privately owned biotechnology company focused on developing molecular diagnostics for sepsis. Its work centers on quantifying host immune responses to infection to enable early detection of sepsis and to guide therapeutic decisions. The company maintains offices in Seattle, Washington and Brisbane, Australia. Its products are designed for clinicians, payers, and healthcare systems, with the aim of addressing unmet clinical needs in suspected sepsis patients. Operating in the biotechnology research sector, Immunexpress emphasizes host-response biomarkers as a diagnostic approach. In March 2026, the company participated in the Society of Critical Care Medicine's Critical Care Congress, presenting data that SeptiCyte RAPID correlates with blood culture–positive sepsis cases.